First images of a possible CO(+)-tail of comet P/Schwassmann-Wachmann 1 observed against the dust coma background

Comet P/Schwassmann-Wachmann 1 was observed with the 2m-Ritchey-Cretien Telescope of the Bulgarian National Observatory, Rozhen, Bulgaria, using the CCD-camera and focal reducer of the Max-Planck-Institute for Aeronomy. Images were taken in a red continuum window and in the 2-0 A(exp 2)Pi - X(exp 2)Sigma(+) band of CO(+) located in the blue part of the spectrum. The red images reveal an extended dust coma. From a comparison of the red and blue images a dust reddening of 13.2 percent per 1000 A is derived. At 642 nm the magnitude of the comet with a square diaphragm of 4.5 arcsec is 16.6. The blue images, taken in the CO(+) band, show a significantly different brightness distribution which is interpreted as presence of a CO(+) coma and tail superimposed on the continuum. A column density of several 10(exp 10) CO(+) molecules cm(exp -2) is derived. The tail thickness of 10(exp 5) km is unexpectedly small. We estimate the CO(+) production rate to about 6 x 10(exp 26) CO(+) particles s(exp -1). This value does not support the idea that the outbursts of this comet are caused by crystallization of amorphous water ice

Doppler velocities in the ion tail of comet Levy 1990c

We have obtained time alternating sequences of column density maps and Doppler velocity fields in the plasma tail of comet Levy 1990c. We describe the observing technique and data analysis, and we present first results

Promoting stigma coping and empowerment in patients with schizophrenia and depression: results of a cluster-RCT

There is a need for interventions supporting patients with mental health conditions in coping with stigma and discrimination. A psycho-educational group therapy module to promote stigma coping and empowerment (STEM) was developed and tested for efficacy in patients with schizophrenia or depression. 30 clinical centers participated in a cluster-randomized clinical trial, representing a broad spectrum of mental health care settings: in-patient (acute treatment, rehabilitation), out-patient, and day-hospitals. As randomized, patients in the intervention group clusters/centers received an illness-specific eight sessions standard psychoeducational group therapy plus three specific sessions on stigma coping and empowerment ('STEM'). In the control group clusters the same standard psychoeducational group therapy was extended to 11 sessions followed by one booster session in both conditions. In total,N = 462 patients were included in the analysis (N = 117 with schizophrenia spectrum disorders, ICD-10 F2x;N = 345 with depression, ICD-10 F31.3-F31.5, F32-F34, and F43.2). Clinical and stigma-related measures were assessed before and directly after treatment, as well as after 6 weeks, 6 months, and 12 months (M12). Primary outcome was improvement in quality of life (QoL) assessed with the WHO-QOL-BREF between pre-assessment and M12 analyzed by mixed models and adjusted for pre-treatment differences. Overall, QoL and secondary outcome measures (symptoms, functioning, compliance, internalized stigma, self-esteem, empowerment) improved significantly, but there was no significant difference between intervention and control group. The short STEM module has proven its practicability as an add-on in different settings in routine mental health care. The overall increase in empowerment in both, schizophrenia and depression, indicates patients' treatment benefit. However, factors contributing to improvement need to be explored. The study has been registered in the following trial registers. ClinicalTrials.gov:Registration number: NCT01655368. DRKS:Registration number: DRKS00004217